The protein characterization and identification market has seen considerable growth due to a variety of factors.
• The market size for protein characterization and identification has seen a swift increase in recent years. It is expected to rise from $18.93 billion in 2024 to $21.61 billion in 2025 with a compound annual growth rate (CAGR) of 14.1%. The expansion during the historic period originates from growth in areas such as proteomics research, the study of disease mechanisms, the integration of bioinformatics, the determination of protein structure, and the transition from genomics to proteomics.
The Protein Characterization And Identification market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for protein characterization and identification is anticipated to witness strong growth in the upcoming years. It is projected to reach $39.82 billion by the year 2029, growing at a compound annual growth rate (CAGR) of 16.5%.
The factors contributing to this growth in the given period include increasing demand for bioinformatics solutions, expansion of biopharmaceuticals, the advancement of precision medicine, augmented research funding, and expansion of biomedical research. Forecasted trends that are expected to influence this market include the evolution of mass spectrometry, application of proteomics in drug development, improvements in chromatography, automation along with high-throughput methods, as well as the integration of bioinformatics.
The protein characterization and identification market is being propelled by the surge in drug development activities. Drug development, the procedure of bringing a new therapeutic molecule into clinical practice, necessitates the precise determination of protein quantities. This is crucial for not just the development of biopharmaceutical drugs but also for numerous other research undertakings. The exactness and precision in measuring protein content are essential as they play a key role in calculating the dosage of the drug product and evaluating several other vital quality aspects. For example, the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade lobby and group, reported that there was a significant increase in drug production value in the pharmaceutical industry, from $385.1 million (€363,300 million) to a projected $413.4 million (€390,000 million) between 2022 and 2023, demonstrating a significant escalation in drug development endeavors. As such, this upswing in drug development activities is catalyzing the growth of the protein characterization and identification market.
The protein characterization and identification market covered in this report is segmented –
1) By Product Type: Consumables, Instruments, Services
2) By Application: Drug Discovery And Development, Clinical Diagnosis
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Research Institutions, Contract Research Organizations, Other End Users
Subsegments:
1) By Consumables: Reagents And Buffers, Sample Preparation Kits, Assay Kits
2) By Instruments: Mass Spectrometers, Chromatography Systems, Spectrophotometers, Electrophoresis Equipment
3) By Services: Analytical Services, Contract Research Services, Custom Protein Characterization Services
The trend of product innovation is central to the protein identification and characterization field. Leading entities in this market are crafting novel solutions to maintain their competitive edge. Take SCIEX, a life science analytical technologies company based in the U.S., as an example - it released the Fast Glycan Labeling and Analysis kit along with an updated version of the Biologics Explorer software in January 2023. This updated software, version 3.0, provides comprehensive sequence coverage and offers users enhanced insights into pivotal modification sites of proteins. The Fast Glycan Labeling and Analysis kit not only ensures dependable, uniform results but also facilitates swift heterogeneity characterization and identification of glycan. These are both examples of crucial methods used for the rapid and precise characterization of biotherapeutics.
Major companies operating in the protein characterization and identification market include:
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Danaher Corporation
• General Electric Company
• The Merck Group
• PerkinElmer Inc.
• Shimadzu Corporation
• Thermo Fisher Scientific Inc.
• Waters Corporation
• Promega Corporation
• Sartorius AG
• Analytik Jena AG
• Sigma-Aldrich Corp.
• Creative Proteomics
• Cleaver Scientific
• Genedata AG
• Proteome Sciences plc
• Selvita S.A.
• Eurofins Scientific SE
• Charles River Laboratories International Inc.
• WuXi AppTec
• Eurogentec S.A.
• Protea Biosciences Group Inc.
• Bioinformatics Solutions Inc.
• Biognosys AG
• Bioproximity LLC
• Biotech Support Group LLC
• Biodesix Inc.
• SGS SA
North America was the largest region in the protein characterization and identification market in 2024. The regions covered in the protein characterization and identification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa